Use of powerful CYP1A2 inhibitors needs to be discontinued prior to initiating pirfenidone and prevented during therapy; if powerful CYP1A2 inhibitors are the only real drug of preference, dosage reductions are proposed eight An interplay concerning host and environmental factors causes repetitive microinjuries of alveolar epithelial cells, simultaneous activation of https://billd333pbl5.qodsblog.com/profile